Authors: Nyholm, B Brock, B Orskov, L Schmitz, O

Citation: B. Nyholm et al., Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus, EXPERT OP I, 10(9), 2001, pp. 1641-1652

Authors: Orskov, L Schmitz, O Bak, JF Lund, S Kaal, A Nyholm, B Moller, N

Citation: L. Orskov et al., Skeletal muscle glucose uptake, glycogen synthase activity and GLUT 4 content during hypoglycaemia in type 1 diabetic subjects, SC J CL INV, 61(5), 2001, pp. 371-381

Authors: Rasmussen, BM Orskov, L Schmitz, O Hermansen, K

Citation: Bm. Rasmussen et al., Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects, METABOLISM, 50(4), 2001, pp. 451-457

Authors: Poulsen, PL Orskov, L Grofte, T Moller, J Holst, JJ Schmitz, O Moller, N

Citation: Pl. Poulsen et al., Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man, METABOLISM, 49(12), 2000, pp. 1598-1603

Authors: Orskov, L Nyholm, B Hove, KY Gravholt, CH Moller, N Schmitz, O

Citation: L. Orskov et al., Effects of the amylin analogue pramlintide on hepatic glucagon responses and intermediary metabolism in Type 1 diabetic subjects, DIABET MED, 16(10), 1999, pp. 867-874

Authors: Nyholm, B Orskov, L Hove, KY Gravholt, CH Moller, N Alberti, KGMM Moyses, C Kolterman, O Schmitz, O

Citation: B. Nyholm et al., The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus, METABOLISM, 48(7), 1999, pp. 935-941